These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 12440162)
1. [Correlation between Fas/Fas-ligand expression and apoptosis in undifferentiated nasopharyngeal carcinoma]. Enami A; Tsutsumi K; Kobayashi T; Shibosawa E; Koizuka I Nihon Jibiinkoka Gakkai Kaiho; 2002 Oct; 105(10):1087-92. PubMed ID: 12440162 [TBL] [Abstract][Full Text] [Related]
2. Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas. Shibosawa E; Tsutsumi K; Koizuka I; Hoshikawa M; Takakuwa T Laryngoscope; 2000 Jan; 110(1):93-7. PubMed ID: 10646722 [TBL] [Abstract][Full Text] [Related]
3. Fas ligand expression in Hodgkin lymphoma. Verbeke CS; Wenthe U; Grobholz R; Zentgraf H Am J Surg Pathol; 2001 Mar; 25(3):388-94. PubMed ID: 11224610 [TBL] [Abstract][Full Text] [Related]
4. Expression of Fas-Fas ligand system associated with atresia in murine ovary. Xu JP; Li X; Mori E; Sato E; Saito S; Guo MW; Mori T Zygote; 1997 Nov; 5(4):321-7. PubMed ID: 9563680 [TBL] [Abstract][Full Text] [Related]
5. Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1. Kouvidou C; Kanavaros P; Papaioannou D; Stathopoulos E; Sotsiou F; Datseris G; Tzardi M; Kittas C; Delides G Clin Mol Pathol; 1995 Feb; 48(1):M17-22. PubMed ID: 16695969 [TBL] [Abstract][Full Text] [Related]
6. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma. He D; Xiao L; Chen JN; Liang Q; Shao CK Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111 [TBL] [Abstract][Full Text] [Related]
7. Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover. Bennett MW; O'Connell J; O'Sullivan GC; Roche D; Brady C; Collins JK; Shanahan F Dis Esophagus; 1999; 12(2):90-8. PubMed ID: 10466040 [TBL] [Abstract][Full Text] [Related]
8. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines. Husain N; Chiocca EA; Rainov N; Louis DN; Zervas NT Acta Neuropathol; 1998 Mar; 95(3):287-90. PubMed ID: 9542594 [TBL] [Abstract][Full Text] [Related]
9. Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors. Fujita H; Koji T; Kitagawa N; Tsutsumi K; Abe K; Kaminogo M; Shibata S Cell Mol Neurobiol; 2002 Aug; 22(4):393-406. PubMed ID: 12507389 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis in rat spontaneous chronic pancreatis: role of the Fas and Fas ligand system. Su SB; Motoo Y; Xie MJ; Sawabu N Dig Dis Sci; 2001 Jan; 46(1):166-75. PubMed ID: 11270781 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer. Wang S; Pudney J; Song J; Mor G; Schwartz PE; Zheng W Gynecol Oncol; 2003 Feb; 88(2):108-17. PubMed ID: 12586588 [TBL] [Abstract][Full Text] [Related]
12. Fas ligand upregulation is an early event in colonic carcinogenesis. Bennett MW; O'Connell J; Houston A; Kelly J; O'Sullivan GC; Collins JK; Shanahan F J Clin Pathol; 2001 Aug; 54(8):598-604. PubMed ID: 11477113 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis of bovine granulosa cells after serum withdrawal is mediated by Fas antigen (CD95) and Fas ligand. Hu CL; Cowan RG; Harman RM; Porter DA; Quirk SM Biol Reprod; 2001 Feb; 64(2):518-26. PubMed ID: 11159354 [TBL] [Abstract][Full Text] [Related]
14. Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Koomägi R; Volm M Int J Cancer; 1999 Jun; 84(3):239-43. PubMed ID: 10371340 [TBL] [Abstract][Full Text] [Related]
15. Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis. Yukawa M; Iizuka M; Horie Y; Yoneyama K; Shirasaka T; Itou H; Komatsu M; Fukushima T; Watanabe S Int J Colorectal Dis; 2002 Mar; 17(2):70-6. PubMed ID: 12014424 [TBL] [Abstract][Full Text] [Related]
16. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Kunitake R; Kuwano K; Miyazaki H; Hagimoto N; Nomoto Y; Hara N Eur Respir J; 1999 Jun; 13(6):1329-37. PubMed ID: 10445608 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2. Yu XZ; Anasetti C Transplantation; 2000 Jan; 69(1):104-12. PubMed ID: 10653388 [TBL] [Abstract][Full Text] [Related]
19. The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas. Gutierrez LS; Eliza M; Niven-Fairchild T; Naftolin F; Mor G Breast Cancer Res Treat; 1999 Apr; 54(3):245-53. PubMed ID: 10445423 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivo. Lee SH; Jang JJ; Lee JY; Kim SY; Park WS; Kim CS; Kim SH; Yoo NJ APMIS; 1998 Nov; 106(11):1035-40. PubMed ID: 9890264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]